We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Faviparivir is a pyrazinecarboxamide-derivative antiviral medication created by chemists in Japan to treat influenza, but its usage has since been expanded to treat other viral infections. It works by preventing viruses from being able to copy their genetic material, something that is essential for the virus’ spread and ability to generate symptoms and failing health in those afflicted with it. This inhibitory effect is made possible by impeding RNA-polymerase activity within affected cells.
Faviparivir is primarily used for treatment of Influenza A and B viruses, and while it is also used to treat Ebola virus, Yellow fever, and Nipah virus these 3 treatments are still under trial. It is also currently being evaluated as a potential treatment for COVID-19 (coronavirus) but this usage also still has yet to be approved in the USA or elsewhere. Among other aspects, it is particularly highly touted for its absorption rate of nearly 98%.
Use of Faviparivir may cause patients to experience any of the following side effects:
Plus, it is important to understand that use of Favipiravir may cause congenital defects and pregnant women should NOT use Favipiravir at any time during their pregnancy.
Favipiravir is sold under the brand name Avigan, and in May 2020 was approved by the US FDA for emergency use as a potential COVID-19 treatment.